Glutamine (Gln) is a "competence factor" necessary for intestinal cell proliferation, intestinal fluid/
electrolyte absorption, and mitogenic response to
growth factors. Gln deprivation produces apoptosis. Gln stimulation of quiescent cells produces immediate-early gene expression and MAP
kinase activation. However,
EGF signals more powerfully through MAPKs than Gln. Interestingly,
EGF-stimulated mitogenesis is ineffective in the absence of Gln. In the intact intestinal epithelia in vivo, Gln has powerful effects on absorption of
sodium and
chloride. Gln-stimulated absorption is greater than and additive to
glucose-stimulated absorption in cryptosporidial
enteritis. In the piglet ileum, Gln metabolism stimulates apical
amiloride-inhibitable Na+/H+ exchange. Although one might predict powerful effects of oral Gln on absorption in babies with
diarrhea, 3 clinical trials to date (one published) have not shown an advantage of Gln-supplemented
oral rehydration solutions (
ORS) compared to standard
glucose ORS. Severely dehydrated subjects have not been studied. More important effects of Gln treatment may be seen with (1) co-administration with a
growth factor and (2) in patients with severe intestinal damage, such as protracted
diarrhea of infancy or
AIDS enteropathy.